Design and rationale of the Reduction of Infarct Expansion and Ventricular Remodeling with Erythropoietin after Large Myocardial Infarction (REVEAL) trial.

Source:http://linkedlifedata.com/resource/pubmed/id/21095264

Download in:

View as

General Info

PMID
21095264